Experimental studies showed that several strains of lupus-prone mice treated with anti-CD40L Abs had reduced anti-DNA autoantibody production prolonged survival, reduced severity of nephritis, and diminished inflammation. Here, CD40LG is linked to systemic lupus erythematosus.